Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics (Q74490010)
Jump to navigation
Jump to search
scientific article published on 01 April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics |
scientific article published on 01 April 1998 |
Statements
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics (English)
A Szczeklik
L Mastalerz
G Bochenek
E Nizankowska
B Dahlén
O Zetterström
M Kumlin
G Pinis
L J Swanson
T I Boodhoo
L M Dubé
S E Dahlén